Cholesterol Drug Fenofibrate Emerges as a Surprising Candidate Against Blinding Eye Disease
A comprehensive review finds that the lipid-lowering drug fenofibrate shows strong clinical evidence for slowing diabetic retinopathy and promising preclinical ...
